AMLX- Amylyx Pharmaceuticals, Inc.

Name: Amylyx Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Amylyx Pharmaceuticals, Inc. (AMLX) has 10 insiders with recent SEC Form 4 filings, including 1 buy and 11 sells. AMLX is classified in the Pharmaceuticals industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Cohen Joshua B	3.32M	$48.95M	-
CEO	Klee Justin B.	3.32M	$48.95M	-
Dir	Milne George M Jr	812.9K	$11.99M	-
CFO	Frates James M	177.1K	$2.61M	-
Other	Bedrosian Camille L	175.8K	$2.59M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jan 6, 2026	Frates James M83	Chief Financial Officer	Sell	3,326	$11.11	$36,953.86	-1.8%	+39.0%	-
Jan 6, 2026	Cohen Joshua B60	Co-chief Executive Officer	Sell	7,715	$11.09	$85,596.38	-0.2%	+39.0%	-
Jan 6, 2026	Klee Justin B.60	Co-chief Executive Officer	Sell	7,715	$11.09	$85,589.44	-0.2%	+39.0%	-
Dec 23, 2025	Firestone Karen	Director	Buy	8,100	$12.45	$100,845.00	+14.7%	+9.9%	-
Dec 1, 2025	Bedrosian Camille L64	Chief Medical Officer	Sell	6,580	$14.35	$94,418.39	-3.6%	+7.4%	-
Sep 30, 2025	Cohen Joshua B60	Co-chief Executive Officer	Sell	29,933	$14.35	$429,468.84	-0.4%	-10.3%	-
Sep 30, 2025	Klee Justin B.60	Co-chief Executive Officer	Sell	29,975	$14.38	$430,952.12	-0.4%	-10.3%	-
Sep 30, 2025	Mazzariello Gina53	Chief Legal Officer	Sell	8,828	$14.58	$128,668.98	-5.6%	-10.3%	-
Sep 30, 2025	Frates James M83	Chief Financial Officer	Sell	10,558	$14.65	$154,650.42	-3.6%	-10.3%	-
Sep 30, 2025	Bedrosian Camille L64	Chief Medical Officer	Sell	12,039	$14.58	$175,517.78	-6.2%	-10.3%	-

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC